| Catalog Number |
D138505 |
| Medical Device Problem Code |
Backflow (1064)
|
| Health Effect - Clinical Code |
No Clinical Signs, Symptoms or Conditions (4582)
|
| Date of Event |
10/07/2025
|
|
Type of Reportable Event
|
Malfunction
|
|
Additional Manufacturer Narrative
|
|
This report is being submitted pursuant to the provisions of 21 cfr, part 803.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by biosense webster, inc., or its employees that the report constitutes an admission that the product, biosense webster, inc.Or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.Manufacturer's reference number: (b)(4).
|
| |
|
Event or Problem Description
|
|
It was reported that a patient underwent an atrial fibrillation ablation procedure with a carto vizigo¿ 8.5f bi-directional guiding short sheath - medium and air was drawn into the device.This occurred when removing the varipulse catheter and inserting an octaray.The hemostatic valve of the vizigo short itself was not damaged.No air entered the patient's body.The device was replaced and the procedure continued.No patient consequences were reported.
|
| |
|
Additional Manufacturer Narrative
|
|
On 4-nov-2025, the bwi product analysis lab received the device for evaluation.The product investigation was subsequently completed.It was reported that a patient underwent an atrial fibrillation ablation procedure with a carto vizigo¿ 8.5f bi-directional guiding short sheath - medium and air was drawn into the device.This occurred when removing the varipulse catheter and inserting an octaray.The hemostatic valve of the vizigo short itself was not damaged.No air entered the patient's body.The device was replaced and the procedure continued.No patient consequences were reported.Device evaluation details: the device was returned to johnson & johnson medtech (j&j medtech) for evaluation.Visual inspection, back pressure test of the returned device were performed following j&j medtech procedures.Visual inspection revealed no damage or anomalies on the device.The hemostatic valve surface does not show stress marks on the outer diameter.A back pressure test was performed, and no issues were observed.A device history record review was performed for the finished device lot number 60000520 and no internal action related to the complaint was found during the review.No bubbles were detected.The air flows back and irrigation issues reported by the customer could not be replicated during the product investigation; other issues or circumstances may have occurred during the usage of the device that compromised its performance.The instructions for use contain the following warning stated in the ifu (instructions for use): use best practices for inserting or retracting any device at the hemostatic valve.Monitor any potential air entrapped and completely aspirate any observed air out of the side port; before inserting the sheath into the patient, flush the sheath and dilator with heparinized normal saline to remove air bubbles and any potential particulate; if resistance is encountered, do not use excessive force to advance or withdraw the catheter through the sheath.As part of johnson & johnson medtech¿s quality process, all devices are manufactured, inspected, and released to approved specifications.If additional information is received regarding this event, a supplemental 3500a report will be submitted to the fda.Manufacturer's reference number: (b)(4).
|
| |
|
Search Alerts/Recalls
|